RNAZ

Transcode Therapeutics Inc Cross-source read$1.89 8.25%
Health CareCUSIP 89357L501· EOD Sep 8, 2026

Among active 13F managers last quarter, none opened or added and 1 reduced; the largest holder to move was Tower Research Capital LLC (TRC) (−74%). No open-market insider trades in the last 180 days.

Tracked 13F holders
8
1 in Q2 2026 filings
13F value (tracked)
$137K
Smart-money readBearish
Net sellingNet buying
Funds · active managers, latest 13F
0 adding · 1 trimming
Insiders · Form 4 open-market, 180d
0 buying · 0 selling
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean out and no leg opposes.

Price & smart-money activity

$1.89 8.25%5Y -100.0%
$1.74$835,260$1,670,519$2,505,777$3,341,0362021202220232024202520263322
Hover for who · click for detailEnd-of-day closing prices52w $1.89 – $15.23

Who owns RNAZ?

8 tracked 13F filers · ranked by shares held

8 tracked 13F filers disclose a position in RNAZ as of the latest SEC 13F filings, a combined $137K in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1UBS Group AG8K
$71K
+180%
Added · +5K sh
Q1 2026
2Vanguard Capital Management LLC7K
$41K
Held
Q2 2026
3Vanguard Fiduciary Trust Co3K
$19K
Held
Q2 2026
4FMR LLC706
$4K
New
+706 sh
Q2 2026
5Tower Research Capital LLC (TRC)228
$2K
−74%
Reduced · −659 sh
Q1 2026
6Wells Fargo & Company55
$474
New
+55 sh
Q1 2026
7SBI Securities Co., Ltd.12
$75
Held
Q2 2026
8Royal Bank Of Canada8
$0
Held
Q1 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is RNAZ being bought or sold by institutions?

Last quarter, no active manager opened or added to a position in RNAZ, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Reduced
1
reduced, still holding
Biggest moves · ranked by size of the change, positions above a floor

Funds that own RNAZ also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA2 funds$539.7M
Invesco QQQ Trust Series 1QQQ2 funds$278.8M
Vanguard S&P 500 ETFVOO2 funds$251.1M
Apple IncAAPL2 funds$248.1M
Micron Technology IncMU2 funds$220.3M
Direx Dail Semi Bu 3X Et-UsdSOXL2 funds$217.6M
Tesla IncTSLA2 funds$178.1M
Microsoft CorpMSFT2 funds$167.8M
Alphabet Inc-CL AGOOGL2 funds$158.2M
Vanguard Tot World STK ETFVT2 funds$124.6M
Amazon.com IncAMZN2 funds$121.4M
Alphabet Inc-CL CGOOG2 funds$96.5M

Ranked by how many of RNAZ's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in RNAZ.

Insider activity (Form 4)

Full insider page →
Net · 180d
$0
0 open-market transactions
DateInsiderRoleActionSharesValue
Sep 28, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy (P)98K$50K
Sep 28, 2023Fitzgerald Thomas AChief Financial Officer, DirectorBuy (P)49K$25K
Jun 21, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy (P)12K$32K
Jun 20, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy (P)7K$17K
Jun 9, 2023Dudley Robert MichaelChief Executive Officer, DirectorBuy (P)19K$52K
Sep 14, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerBuy (P)20K$23K
Jun 16, 2022Fitzgerald Thomas AChief Financial Officer, DirectorBuy (P)12K$15K
May 31, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerBuy (P)2K$4K
May 27, 2022Dudley Robert MichaelChief Executive Officer, Director, 10% OwnerBuy (P)28K$52K

Do institutions, insiders and Congress agree?

Mixed signals

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
11
Insiders
Form 4 open-market
00$0
US House
STOCK Act trades
00$0
Sector rotation
RNAZ is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

1 tracked filers in Q2 2026 filingsstill filing
059Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $75
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

15 most recent

Keep exploring

Connected entities for RNAZ

Browse more

Build

Ask your agent what changed in RNAZ

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/RNAZ/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for RNAZ.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for RNAZ. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.